NEWS AND PUBLICATIONS

Major development in the prosecution of life sciences patents in Brazil: ANVISA is kicked out of the process

After being sanctioned by the Presidency, a Brazilian statute suppressing the role played by the National Health Surveillance Agency – ANVISA (the Brazilian FDA) in the examination of patent applications pertaining to the life sciences field was published today in the...